L. Mignot

4.1k total citations
103 papers, 2.7k citations indexed

About

L. Mignot is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, L. Mignot has authored 103 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in L. Mignot's work include Cancer Treatment and Pharmacology (16 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cancer Risks and Factors (10 papers). L. Mignot is often cited by papers focused on Cancer Treatment and Pharmacology (16 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cancer Risks and Factors (10 papers). L. Mignot collaborates with scholars based in France, United States and Italy. L. Mignot's co-authors include Jean‐Yves Pierga, Véronique Dièras, M. Marty, François‐Clément Bidard, Marc Espié, Guy‐Alain Junter, Fabien Calvo, Christophe Fermé, Jean Marc Extra and Anne Vincent‐Salomon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

L. Mignot

99 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Mignot France 30 1.4k 717 581 344 310 103 2.7k
Carmen Guillén‐Ponce Spain 24 1.0k 0.7× 434 0.6× 463 0.8× 384 1.1× 207 0.7× 133 1.9k
Giorgio Stanta Italy 33 1.0k 0.7× 598 0.8× 693 1.2× 1.5k 4.5× 408 1.3× 131 3.7k
Trilok Parekh United States 24 1.3k 0.9× 908 1.3× 314 0.5× 875 2.5× 365 1.2× 64 2.6k
Myoung Hee Kang South Korea 25 857 0.6× 322 0.4× 337 0.6× 885 2.6× 261 0.8× 63 2.1k
Min Sun China 24 351 0.2× 505 0.7× 541 0.9× 808 2.3× 421 1.4× 111 2.3k
Alessandra Cassano Italy 29 1.6k 1.1× 880 1.2× 448 0.8× 735 2.1× 512 1.7× 151 3.0k
Masaaki Tachibana Japan 34 1.6k 1.1× 1.3k 1.8× 877 1.5× 1.3k 3.9× 1.9k 6.1× 187 4.9k
Yunpeng Yang China 33 2.4k 1.6× 1.5k 2.2× 645 1.1× 951 2.8× 513 1.7× 220 4.1k
Alina V. Brenner United States 36 815 0.6× 742 1.0× 352 0.6× 592 1.7× 314 1.0× 111 4.2k
Ronald A. Fleming United States 30 1.3k 0.9× 457 0.6× 113 0.2× 745 2.2× 922 3.0× 81 3.2k

Countries citing papers authored by L. Mignot

Since Specialization
Citations

This map shows the geographic impact of L. Mignot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Mignot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Mignot more than expected).

Fields of papers citing papers by L. Mignot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Mignot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Mignot. The network helps show where L. Mignot may publish in the future.

Co-authorship network of co-authors of L. Mignot

This figure shows the co-authorship network connecting the top 25 collaborators of L. Mignot. A scholar is included among the top collaborators of L. Mignot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Mignot. L. Mignot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dien, Alicia Tran, L. Mignot, Martina Pagliuca, et al.. (2023). 29P Prevalence of high tumor mutational burden (TMB) in patients with metastatic breast cancer (mBC) assessed by liquid biopsy (LB). ESMO Open. 8(1). 101253–101253. 2 indexed citations
2.
Chvetzoff, Gisèle, Carole Bouleuc, Audrey Lardy-Cléaud, et al.. (2022). Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS. Supportive Care in Cancer. 31(1). 82–82. 5 indexed citations
3.
Barrière, P., Mario Campone, C. Lemanski, et al.. (2017). Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer. European Journal of Cancer. 79. 72–80. 58 indexed citations
4.
Hélissey, Carole, Frédérique Berger, Paul Cottu, et al.. (2015). Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial. Cancer Letters. 360(2). 213–218. 44 indexed citations
5.
Cacheux, Wulfran, et al.. (2011). Targeted biotherapy in metastatic colorectal carcinoma: Current practice. Journal of Visceral Surgery. 148(1). 12–18. 11 indexed citations
6.
Bidard, François‐Clément, Jean‐Yves Pierga, Véronique Girre, et al.. (2011). Méningites carcinomateuses des cancers du sein. Bulletin du Cancer. 98(4). 391–398. 3 indexed citations
7.
Bidard, François‐Clément, Jean‐Yves Pierga, V. Girre, et al.. (2010). Survival of breast cancer patients with meningeal carcinomatosis. Annals of Oncology. 21(11). 2183–2187. 122 indexed citations
8.
Cottu, P., Véronique Dièras, Anne Vincent‐Salomon, et al.. (2010). Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience. Annals of Oncology. 22(4). 848–856. 67 indexed citations
9.
Mignot, L., et al.. (2009). Évaluation des antibiothérapies curatives dans les services de chirurgie orthopédique d’un CHG. Médecine et Maladies Infectieuses. 40(5). 285–291. 2 indexed citations
10.
Dièras, Véronique, Anne Vincent‐Salomon, Armelle Degeorges, et al.. (2007). [Trastuzumab (Herceptin) and breast cancer: mechanisms of resistance].. PubMed. 94(3). 259–66. 14 indexed citations
11.
Mignot, L.. (2002). Pregnancy and breast carcinoma: the senologist's point of view. Bulletin du Cancer. 89(9). 1 indexed citations
12.
Mignot, L.. (2002). Cancer du sein et grossesse : le point de vue du sénologue. Bulletin du Cancer. 89(9). 3 indexed citations
13.
Lebrét, Thierry, Jean-Marie Hervé, Laurent Yonneau, et al.. (2002). After Cystectomy, Is It Justified to Perform a Bladder Replacement for Patients with Lymph Node Positive Bladder Cancer?. European Urology. 42(4). 344–349. 29 indexed citations
14.
Lebeau, Thierry, Pierre Gaudin, Guy‐Alain Junter, L. Mignot, & J.-M. Robert. (2000). Continuous marennin production by agar-entrapped Haslea ostrearia using a tubular photobioreactor with internal illumination. Applied Microbiology and Biotechnology. 54(5). 634–640. 15 indexed citations
15.
Mignot, L., et al.. (1997). Cadmium biosorption by Pseudomonas putida entrapped in gel beads of sugar beet pectin. 1 indexed citations
16.
Cottu, Paul, Sylvie Giacchetti, L. Mignot, et al.. (1994). High dose chemotherapy with stem-cell transplantation in a metastatic medulloblastoma in an adult: a case report and review of the literature. Journal of Neuro-Oncology. 18(1). 19–23. 8 indexed citations
17.
Pujade-Lauraine, Éric, Nicoletta Colombo, Éric François, et al.. (1993). [Intraperitoneal administration of interferon gamma. An efficient adjuvant to the chemotherapy of ovarian cancers. Apropos of an European study of 108 patients].. PubMed. 80(2). 163–70. 4 indexed citations
18.
Chevallier, B, L. Mignot, T. Delozier, et al.. (1992). Phase II study of tetrahydropyranyl adriamycin (pirarubicin) in elderly patients with advanced breast cancer.. PubMed. 15(5). 395–8. 6 indexed citations
19.
Extra, Jean Marc, Marc Espié, Fabien Calvo, et al.. (1990). Phase I study of oxaliplatin in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 25(4). 299–303. 295 indexed citations
20.
Bousser, J, C. N. Dao, R Zittoun, & L. Mignot. (1976). Macroglobulinémie de Waldenström avec splénomégalie myéloïde. 127. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Guillén‐Ponce Breakdown of academic impact, for papers by Giorgio Stanta Breakdown of academic impact, for papers by Trilok Parekh Breakdown of academic impact, for papers by Myoung Hee Kang Breakdown of academic impact, for papers by Min Sun Breakdown of academic impact, for papers by Alessandra Cassano Breakdown of academic impact, for papers by Masaaki Tachibana Breakdown of academic impact, for papers by Yunpeng Yang Breakdown of academic impact, for papers by Alina V. Brenner Breakdown of academic impact, for papers by Ronald A. Fleming
Rankless by CCL
2026